Supernus Pharmaceuticals
SUPN
SUPN
242 hedge funds and large institutions have $1.86B invested in Supernus Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 90 increasing their positions, 76 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.55% more ownership
Funds ownership: 102.48% → 104.03% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
23% less call options, than puts
Call options by funds: $2.16M | Put options by funds: $2.79M
Holders
242
Holding in Top 10
3
Calls
$2.16M
Puts
$2.79M
Top Buyers
| 1 | +$14.2M | |
| 2 | +$9.78M | |
| 3 | +$8.24M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$7.62M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$7.34M |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$7.46M | |
| 3 | -$7.06M | |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$5.23M |
| 5 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
-$4.82M |